These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18346629)

  • 1. Capturing the value of complementary and alternative medicine: including patient preferences in economic evaluation.
    Hollinghurst S; Shaw A; Thompson EA
    Complement Ther Med; 2008 Feb; 16(1):47-51. PubMed ID: 18346629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Square pegs and round holes? A review of economic evaluation in complementary and alternative medicine.
    Hulme C; Long AF
    J Altern Complement Med; 2005 Feb; 11(1):179-88. PubMed ID: 15750380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing appropriate measures of the benefits of complementary and alternative medicine.
    Meenan R
    J Health Serv Res Policy; 2001 Jan; 6(1):38-43. PubMed ID: 11219359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paradox of non-evidence based, publicly funded complementary alternative medicine in the English National Health Service: An explanation.
    Sheppard MK
    Health Policy; 2015 Oct; 119(10):1375-81. PubMed ID: 25837235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providing Complementary and Alternative Medicine in primary care: the primary care workers' perspective.
    van Haselen RA; Reiber U; Nickel I; Jakob A; Fisher PA
    Complement Ther Med; 2004 Mar; 12(1):6-16. PubMed ID: 15130567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration and reimbursement of complementary and alternative medicine by managed care and insurance providers: 2000 update and cohort analysis.
    Pelletier KR; Astin JA
    Altern Ther Health Med; 2002; 8(1):38-9, 42, 44 passim. PubMed ID: 11795621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is complementary and alternative medicine (CAM) cost-effective? A systematic review.
    Herman PM; Craig BM; Caspi O
    BMC Complement Altern Med; 2005 Jun; 5():11. PubMed ID: 15932647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Evaluation of Complementary and Alternative Medicine in Oncology: Is There a Difference Compared to Conventional Medicine?
    Huebner J; Prott FJ; Muecke R; Stoll C; Buentzel J; Muenstedt K; Micke O;
    Med Princ Pract; 2017; 26(1):41-49. PubMed ID: 27607437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization, patient satisfaction, and cost implications of acupuncture, massage, and naturopathic medicine offered as covered health benefits: a comparison of two delivery models.
    Stewart D; Weeks J; Bent S
    Altern Ther Health Med; 2001; 7(4):66-70. PubMed ID: 11452569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual choice health insurance policy: a proposal and a cost analysis.
    Cheng J; Ives JC
    J Health Care Finance; 2009; 36(2):60-70. PubMed ID: 20499722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Swiss basic health insurance costs of complementary and conventional medicine.
    Studer HP; Busato A
    Forsch Komplementmed; 2011; 18(6):315-20. PubMed ID: 22189362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trends in the integration and reimbursement of complementary and alternative medicine by managed care, insurance carriers, and hospital providers.
    Pelletier KR; Marie A; Krasner M; Haskell WL
    Am J Health Promot; 1997; 12(2):112-22. PubMed ID: 10174663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and perceived effectiveness of complementary and alternative medicine in patients with dystonia.
    Junker J; Oberwittler C; Jackson D; Berger K
    Mov Disord; 2004 Feb; 19(2):158-61. PubMed ID: 14978670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of sickness absence in chronically ill patients receiving complementary and alternative medicine: a longterm prospective intermittent study.
    Moebus S; Lehmann N; Bödeker W; Jöckel KH
    BMC Public Health; 2006 Feb; 6():28. PubMed ID: 16472403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical implications of the increasing use of complementary and alternative medicine.
    Teichfischer P
    Forsch Komplementmed; 2012; 19(6):311-8. PubMed ID: 23343586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Working complementary therapies into mainstream health care.
    Laurenson M
    Br J Nurs; 2006 Apr 13-26; 15(7):356-8. PubMed ID: 16723933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal systems of complementary and alternative medicine: a cross-sectional survey at a pediatric emergency department.
    Zuzak TJ; Zuzak-Siegrist I; Rist L; Staubli G; Simões-Wüst AP
    J Altern Complement Med; 2010 Apr; 16(4):473-9. PubMed ID: 20374101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The demographics and economics of complementary alternative medicine.
    Lundgren J; Ugalde V
    Phys Med Rehabil Clin N Am; 2004 Nov; 15(4):955-61, ix. PubMed ID: 15458762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blending the boundaries: steps toward an integration of complementary and alternative medicine into mainstream practice.
    Giordano J; Boatwright D; Stapleton S; Huff L
    J Altern Complement Med; 2002 Dec; 8(6):897-906. PubMed ID: 12614540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.